Myeloperoxidase uses hydrogen peroxide (H 2 O 2 ) to generate hypochlorous acid (HOCl), a potent cytotoxic oxidant. We demonstrate that HOCl regulates the activity of matrix metalloproteinase-7 (MMP-7, matrilysin) in vitro, suggesting that this oxidant activates MMPs in the artery wall. Indeed, both MMP-7 and myeloperoxidase were colocalized to lipid-laden macrophages in human atherosclerotic lesions. A highly conserved domain called the cysteine switch has been proposed to regulate MMP activity. When we exposed a synthetic peptide that mimicked the cysteine switch to HOCl, HPLC analysis showed that the thiol residue reacted rapidly, generating a near-quantitative yield of products. Tandem mass spectrometric analysis identified the products as sulfinic acid, sulfonic acid, and a dimer containing a disulfide bridge. In contrast, the peptide reacted slowly with H 2 O 2 , and the only product was the disulfide. Moreover, HOCl markedly activated pro-MMP-7, an MMP expressed at high levels in lipid-laden macrophages in vivo. Tandem mass spectrometric analysis of trypsin digests revealed that the thiol residue of the enzyme's cysteine switch domain had been converted to sulfinic acid. Thiol oxidation was associated with autolytic cleavage of pro-MMP-7, strongly suggesting that oxygenation activates the latent enzyme. In contrast, H 2 O 2 failed to oxidize the thiol residue of the protein or activate the enzyme. Thus, HOCl activates pro-MMP-7 by converting the thiol residue of the cysteine switch to sulfinic acid. This activation mechanism is distinct from the well-studied proteolytic cleavage of MMP pro-enzymes. Our observations raise the possibility that HOCl generated by myeloperoxidase contributes to MMP activation, and therefore to plaque rupture, in the artery wall. HOCl and other oxidants might regulate MMP activity by the same mechanism in a variety of inflammatory conditions.
Proteolysis of structural and adhesive matrix proteins by infiltrating cells is a key event in many destructive inflammatory conditions (1) . The role of macrophage-derived matrix metalloproteinases (MMPs) 1 in mediating plaque rupture in atherosclerosis provides a physiologically relevant example of this process (2, 3) . Formation of a thrombus over a ruptured atherosclerotic plaque precipitates most cases of acute myocardial infarction (4, 5) . Atherosclerotic lesions resistant to rupture are stabilized by a fibrous cap, which separates an intensely procoagulant lipid core from the bloodstream. Because the extracellular matrix plays a key structural role in stabilizing this cap, matrix-degrading enzymes, and MMPs, in particular, might contribute to plaque instability (1) (2) (3) (4) (5) . Indeed, the lipidladen macrophages that congregate in the shoulder regions of human atherosclerotic lesions express several MMPs: collagenase-1 (MMP-1), stromelysin-1 (MMP-3), and gelatinase B (MMP-9) (6 -8) . In contrast, expression of matrilysin (MMP-7) and macrophage metalloelastase (MMP-12) is confined to lipidladen macrophages on the border of the acellular lipid cores (9) . Because pathology studies show that this border region is particularly prone to rupture, dysregulation of MMP activity could represent an important mechanism controlling degradation of structural matrix proteins. Because of its precise location in the artery wall and its broad degradative ability, MMP-7 might be particularly important for triggering tissue disruption and plaque rupture.
MMPs are produced in a latent form, and hence the mechanisms that activate pro-MMPs are important steps in regulating matrix degradation in the artery wall (1) (2) (3) (4) (5) . Several proMMPs have furin cleavage sites (10 -12) and are activated intracellularly in the secretion pathway. However, because most MMPs, including pro-MMP-1, -3, -7, and -9, which are expressed by macrophages in atherosclerotic lesions, are not activated by furin proteolysis, other cell-directed mechanisms must convert the latent enzymes into active form.
With the exception of MMP-23 (1, 13) , the pro-domain of all known MMPs has a highly conserved thiol residue within the consensus sequence PRCXXPD. The catalytic domain of all MMPs exhibits a metazincin fold that contains an active site zinc that binds to three conserved histidines in the sequence HEXXHXXGXXHS/T(X) 5 M (1). In an inactive state, the conserved cysteine residue in the pro-domain provides the fourth coordination site for the catalytic zinc ion (14, 15) . This so-called cysteine-switch domain has been proposed to prevent latent enzymes from becoming inappropriately active by binding to the catalytic zinc atom (16) . Alternatively, the cysteine residue may act in concert with other residues to control the conformation of the pro-domain, shielding the enzyme's active site from substrate (17) .
In vitro, MMPs become active when proteolytic cleavage releases the pro-domain, exposing the zinc atom and freeing the catalytic site to interact with substrate (1) . Although proteolytic activation of MMPs has been widely studied, it is not clear whether this process occurs in vivo or if cleavage of the pro-domain is even required for activity. Many in vitro studies have shown that plasmin can activate latent MMPs, leading to the proposal that this abundant serine proteinase cleaves proMMPs in tissues. Indeed, neointimal formation and breakdown of medial lamellar matrix are reduced in injured arteries in plasminogen and urokinase-like plasminogen activator knockout mice crossed with apolipoprotein E-deficient mice (18, 19) . Because elastin is the main matrix component of aortic lamellae and because this protein polymer is not degraded by plasmin or urokinase-like plasminogen activator, the authors of these studies concluded that elastolytic MMPs, such as MMP-9, are proteolytically activated by these serine proteinases. However, only indirect in vitro evidence was provided to support this idea. Thus, other mechanisms may be involved in pro-MMP activation.
Reactive oxygen and nitrogen species also regulate MMP activity in vitro (20 -26) , suggesting that generation of such species by cells of the artery wall could provide a mechanism for MMP activation in vivo (26, 27) . Myeloperoxidase, a heme protein secreted by phagocytic cells, is one potential source of reactive oxygen species (28 -30) . This enzyme, which colocalizes in part with lipid-laden macrophages in human atherosclerotic lesions (31), uses hydrogen peroxide (H 2 O 2 ) to generate hypochlorous acid (HOCl) (32, 33) .
HOCl is a potent cytotoxic oxidant that converts latent collagenase-2 (MMP-8) and MMP-9 into proteolytically active enzymes (20, 21) . Moreover, levels of characteristic amino acid oxidation products of myeloperoxidase are greatly elevated in atherosclerotic tissue (34 -38) , and both the enzyme and proteins that appear to have been modified by HOCl accumulate in ruptured or eroded sites of human coronary atheroma (39) . Collectively, these observations suggest that HOCl production by myeloperoxidase might provide one pathway for regulating MMP activity in vascular tissue. HOCl reacts rapidly and nearly quantitatively with thiols, thioethers, and amino groups (40 -43) . Therefore, this hypohalous acid might activate latent MMPs by covalently modifying the thiol residue of the pro-enzyme's cysteine switch. In the current studies, we demonstrate that HOCl, but not H 2 O 2 , oxygenates the thiol residue of the cysteine switch of pro-MMP-7. As the thiol is converted to a sulfinic acid, the proenzyme converts to an active form. These observations reveal a molecular mechanism for activating MMPs that is distinct from the generally accepted proteolytic cleavage mechanism. Our findings also suggest that HOCl production by myeloperoxidase might be a physiologically relevant pathway for triggering MMP activation and plaque rupture in the human artery wall.
EXPERIMENTAL PROCEDURES

Materials
Sodium hypochlorite (NaOCl), hydrogen peroxide (H 2 O 2 ), HEPES, trifluoroacetic acid, and HPLC grade CH 3 A (150 mM NaCl, 10 mM HEPES (pH 7.4), 5 mM CaCl 2 ) by dialysis (Slide-A-Lyzer Mini dialysis unit, 10,000 molecular weight cutoff, Pierce, Rockford, IL) or by ultrafiltration (Microcon YM-10 centrifugal filter; Millipore, Bedford, MA) before use. Myeloperoxidase (A 430 /A 280 ratio Ͼ 0.8) was purified from HL-60 cells by sequential lectin affinity, ion exchange, and size exclusion chromatographies (44, 45 (47, 48) . HPLC Analysis of Cysteine Switch Peptide-Peptides were separated at a flow rate of 0.3 ml/min on a reverse-phase column (Vydac C18 MS, 2.1 ϫ 250 mm) using a Beckman HPLC system (Fullerton, CA) with UV detection at 214 nm. The peptides were eluted using a linear gradient of 15% to 30% CH 3 CN in 0.04% trifluoroacetic acid over 20 min.
Proteolytic Digestion-Pro-MMP-7 was incubated overnight at 37°C with sequencing grade-modified trypsin (Promega, Madison, WI) at a ratio of 25:1 (w/w) pro-MMP-7:trypsin in buffer B (10% CH 3 CN, 50 mM NH 4 HCO 3 , pH 8). EDTA (10 mM) was included to block any autolysis by trypsin-activated MMP-7. Digestion was halted by freezing or acidification (pH 2-3) with formic acid or trifluoroacetic acid.
Liquid Chromatography Electrospray Ionization Mass Spectrometry-LC/MS analyses were performed in the positive ion mode with a Finnigan Mat LCQ ion trap instrument (San Jose, CA) coupled to a Waters 2690 HPLC system (Milford, MA). Peptides were separated at a flow rate of 0.2 ml/min on a reverse-phase column (Vydac C18 MS column; 2.1 ϫ 25 mm) using solvent A (0.2% formic acid in water) and solvent B (0.2% formic acid in 80% CH 3 CN, 20% water). Peptides were eluted using the following linear gradient: 0% to 15% B over 15 min; 15% to 30% B over 25 min; then 30% to 65% B over 20 min. The electrospray needle was held at 4500 V. Nitrogen, the sheath gas, was set at 80 units. The collision gas was helium. The temperature of the heated capillary was 220°C.
Pro-MMP-7 Proteolytic Activity-The enzymatic activity of pro-MMP-7 was assayed (49) for 20 min at 37°C using the fluorescent synthetic peptide (7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-Leu-␤-(2,4-dinitrophenylamino)Ala-Ala-Arg-NH 2 (Mca peptide, Sigma). Pro-MMP-7 (15-30 ng) was added to individual wells of a 96-well microtiter plate containing 500 l of buffer C (0.2 M NaCl, 50 mM Tris-HCl (pH 7.5), 10 mM CaCl 2 , 0.02% NaN 3 , 0.05% Brij35 (w/v)) and 2 M Mca peptide. Fluorescence ( ex ϭ 328 nm, em ϭ 392 nm) was monitored using a microplate reader (SPECTRAmax GEMINI XS, Molecular Devices, Sunnyvale, CA). Control reactions indicated that neither HOCl, methionine, nor other components of the oxidation reactions affected the Mca peptide.
Immunohistochemistry-Specimens of atherosclerotic carotid endarterectomies (n ϭ 5) were obtained at surgery, fixed, processed for paraffin embedding, and immunostained as described previously (9). 
Anti-human matrilysin monoclonal antibody was purchased from Chemicon (MAB13414), used at 1:100 dilution, and detected using an alkaline phosphatase mouse IgG kit and Substrate Kit 3 (Vector Laboratories, Inc., Burlingame, CA). Anti-human myeloperoxidase rabbit polyclonal antibodies (31, 50) were used at a 1:400 dilution and by using an Elite rabbit IgG kit (Vector) and 3,3Ј-diaminobenzidine tetrahydrochloride as the chromogenic substrate. Sections stained for myeloperoxidase were lightly counterstained with Harris hematoxylin. For negative controls, sections were processed with preimmune serum at comparable dilutions.
RESULTS
HOCl and H 2 O 2 Generate Different Products When They
Oxidize the Cysteine Switch Peptide-The cysteine switch domain (PRCXXPD) is found in all known MMPs, except for MMP-23 (1, 13) . To explore its possible involvement in MMP activation by oxidants, we used a synthetic peptide, PRCGVP-DVA, which duplicates the switch domain of pro-MMP-7. We exposed the peptide to a 5-fold molar excess of H 2 O 2 or HOCl at 37°C in neutral buffer containing plasma concentrations of chloride and calcium. HPLC revealed one major peak of new material after H 2 O 2 treatment (Fig. 1B, peak 3 ) but three prominent peaks after HOCl treatment ( Fig. 1D; peaks 1, 2 , and 3). Minor peaks that appeared after HOCl treatment (Fig.  1C ) proved difficult to characterize and were not investigated further. We also observed three prominent peaks of material after we exposed the peptide to myeloperoxidase and H 2 O 2 (Fig. 1C) , a system that generates HOCl by oxidizing chloride. The three peptides had identical retention times to those that appeared after HOCl exposure, strongly implicating HOCl in the enzymatic reaction pathway. These observations indicate that H 2 O 2 and HOCl react with the cysteine switch peptide by different pathways, yielding distinct patterns of oxidation products.
HOCl Oxygenates the Cysteine Residue of the Cysteine Switch Peptide-We used LC/MS with an ion-trapping instrument to determine the molecular details of cysteine switch oxidation by HOCl or H 2 O 2 . Electrospray ionization-mass spectrometry analysis of control peptide detected a major ion at m/z 913.6 ( Fig. 2A) , the predicted molecular mass of the protonated cysteine switch peptide ([peptide ϩ H] ϩ ). The isotopic pattern of the ion confirmed that it had one positive charge ( Fig. 2A,  inset) .
The sequence of the cysteine switch peptide was confirmed using an ion trapping instrument and MS/MS and MS/MS/MS analysis, which selects a precursor ion for low energy gas phase collisional activation and subjects the resulting product ions to MS. Under these conditions, peptide ions fragment primarily at the amide bond, yielding a ladder of sequence ions (51) . Retention of charge on the N-terminal portion of the peptide ion yields a b-type ion; retention on the C-terminal portion of the peptide ion yields a y-type ion. Subtracting the masses of adjacent ions reveals the amino acid sequence. An ion-trapping instrument allows this process to be iterated ( (Fig. 2B ). When the m/z 725.5 ion (b 7 ) in the MS/MS mass spectrum was subjected to MS 3 analysis, a ladder of b-type ions corresponding to the entire sequence of the peptide was apparent (Fig. 2C) .
We then characterized the compounds from the three peaks that appeared after we exposed the cysteine switch peptide to HOCl or to H 2 O 2 plus myeloperoxidase (Figs. 1C, 1D, and 3A) . LC/MS analysis of the peak 2 material (Figs. 1B, 1C , and 3A) revealed major ions at m/z 481.3 and 961.5 (Fig. 3D) , the predicted masses of the doubly charged cysteine switch peptide plus 3 oxygens ([peptide ϩ 48 atomic mass units ϩ 2H] 2ϩ ) and the singly charged cysteine switch peptide plus 3 oxygens ([peptide ϩ 48 atomic mass units ϩ H] ϩ ). MS/MS analysis of the m/z 561.5 ion (Fig. 3E ) demonstrated that the cysteine residue had gained 48 atomic mass units, strongly suggesting that its thiol group had been oxidized to sulfonic acid (RSO 3 H). Collectively, these observations indicate that HOCl converts the thiol residue of the cysteine switch peptide to sulfinic acid and sulfonic acid.
HOCl and H 2 O 2 Cross-link Cysteine Switch Peptides into a Dimer Containing a Disulfide
Bond-MS analysis of the peak 3 material (Figs. 1B and 4A ) revealed a major ion at m/z 912.8 (Fig. 4B) , the predicted mass of a doubly charged dimer (RSSR) containing a disulfide cross-link ([peptide ϩ peptide Ϫ 2H ϩ 2H] 2ϩ ). The isotopic pattern of the ion indicated that the dimer was doubly charged (Fig. 4B, inset) . We confirmed that the material in peak 3 had the same structure as the disulfidebonded dimer of the cysteine switch peptide by LC/MS/MS. This demonstrated an ion of m/z 724.5 (Fig. 4C) , which is consistent with loss of two amino acid residues from both peptides in neutral buffer containing plasma concentrations of chloride and calcium. A 60-min exposure to a 2-fold molar excess of H 2 O 2 converted about half the peptide to the disulfide-linked dimer (Fig. 5A) , which was the only product. Adding nanomolar concentrations of myeloperoxidase to the mixture increased the reaction rate more than 20-fold (Fig. 5B) . The product yield also increased; nearly all of the peptide was converted to roughly equal amounts of dimer and the sulfinic acid derivative.
HOCl reacted much more rapidly with the peptide than did H 2 O 2 (Fig. 5C ). The major oxidation product generated by HOCl was the disulfide cross-linked dimer and sulfinic acid. When the mole ratio of HOCl to peptide was 1:1, conversion of cysteine switch peptide to oxidation products was nearly quantitative (Fig. 5D) . As the ratio increased, so did the yield of the sulfinic acid oxidation product (Fig. 5D) . Collectively, these observations indicate that HOCl reacts much more readily than H 2 O 2 with the thiol group of the cysteine switch peptide and that continuous, slow production of HOCl by the myeloperoxidase-H 2 O 2 system favors oxygenation of the thiol.
Colocalization of MMP-7 and Myeloperoxidase in Atherosclerotic Lesions-Because both MMP-7 and myeloperoxidase are localized to subpopulations of macrophages in human atherosclerotic lesions (9, 31), we examined whether these two enzymes are present in the same cells and areas. Indeed, immunohistochemistry of serial sections of human atherosclerotic arteries (n ϭ 5) revealed that both MMP-7 and myeloperoxidase were seen in foamy macrophage-like cells at the border between lipid cores and surrounding the cellular, matrix-rich tissue (Fig. 6) . Consistent with previous observations (9), staining for MMP-7 was confined to cells along the edge of the lipid cores. In contrast, signal for myeloperoxidase protein was seen in macrophages in several areas of the lesions (data not shown). The colocalization of myeloperoxidase and MMP-7 suggests that HOCl would be generated by the same subpopulation of macrophages expressing this MMP.
HOCl Activates Pro-MMP-7-To determine whether HOCl can convert pro-MMP-7 to an active form by oxygenating the cysteine switch, we exposed the pro-enzyme to HOCl and determined whether the mixture could degrade Mca, a synthetic fluorescent peptide (49) . Pro-MMP-7 exposed to increasing concentrations of HOCl initially increased its proteolytic activity, which became optimal at a mole ratio of ϳ50:1 of HOCl to protein (Fig. 7) . Higher HOCl concentrations inhibited proteolysis. In striking contrast, the proteolytic activity of pro-MMP-7 failed to increase during exposure to the same range of H 2 O 2 concentrations. These observations indicate that HOCl, but not H 2 O 2 , is able to convert pro-MMP-7 to an enzymatically active form.
HOCl Oxygenates the Cysteine Switch Domain of Pro-MMP-7-Our demonstration that HOCl oxygenates the thiol group of the cysteine switch peptide suggests that a similar reaction might be able to activate pro-MMP-7. To explore this possibility, we digested unmodified pro-MMP-7 with trypsin and identified the resulting peptides through LC/MS (Table I) . The peptides covered 92% of the protein's sequence. We were unable to identify small peptides and single amino acid residues FIG. 6 . Colocalization of myeloperoxidase and MMP-7 in atherosclerotic plaques. Serial sections of atherosclerotic carotid endarterectomy specimens were immunostained for MMP-7 or myeloperoxidase (MPO). Staining for both proteins was seen in macrophage-like cells (arrows) along the border of lipid cores (LC). MMP-7-antibody complexes were detected using a blue substrate; for myeloperoxidase, complexes were visualized with 3,3Ј-diaminobenzidine tetrahydrochloride, which is seen as a brown precipitate. The MMP-7 monoclonal antibody produced weak background in the lipid core, which was also seen in the preimmune control (data not shown), and a tissue separation artifact was created during sectioning of the sample stained for myeloperoxidase. (Fig. 8, A and B) . MS/MS analysis of the m/z 912.3 ion demonstrated a series of b ions and y ions that would be expected to form from the peptide containing the cysteine residue of the cysteine switch domain (Fig. 8C) .
When pro-MMP-7 spontaneously converts to active MMP-7 in vitro, its pro-domain is cleaved by autolysis at Glu 77 -Tyr 78 (51) . If HOCl oxygenates the thiol residue of the pro-domain without activating pro-MMP-7, the peptide C(SO 2 H) GVPDVAE 77 Y 78 SLFPNSPK should appear in the trypsin digest. In contrast, if oxygenation of the cysteine switch domain activates pro-MMP-7, the zymogen would be cleaved at Glu 77 -Tyr 78 to yield the peptide C(SO 2 H)GVPDVAE 77 . To distinguish between these possibilities, we exposed pro-MMP-7 to HOCl at a mole ratio of 50:1, digested the oxidized enzyme with trypsin, and subjected the peptide mixture to LC/MS. A new peptide in the proteolytic digest had a mass of 821.2 (Fig. 9,  A and B) , the predicted m/z of the protonated peptide ([C(SO 2 H)GVPDVAE 77 ϩ H]) ϩ . MS/MS analysis confirmed the sequence of the peptide and demonstrated that the cysteine residue had gained 32 atomic mass units (Fig. 9C) . In contrast, we failed to detect peptides of m/z 1853.5 or 928.3, the predicted m/z of the singly and doubly charged species of the peptide C(SO 2 H)GVPDVAE 77 Y 78 SLFPNSPK. These results indicate that HOCl converts the thiol residue of the cysteine switch domain of pro-MMP-7 to the sulfinic acid derivative. In contrast, LC/MS analysis of the trypsin digest of pro-MMP-7 exposed to H 2 O 2 failed to identify ions consistent with formation of the sulfinic acid derivative.
Our observation that HOCl-treated pro-MMP-7 is cleaved at Glu 77 -Tyr 78 strongly implicates oxygenation in pro-MMP-7 activation (see Fig. 11 ). To explore this possibility, we exposed the proenzyme to HOCl. We then monitored the relative intensities of the ions derived from the trypsin digest of both the unmodified cysteine switch domain (m/z 912. ). The intensity of the ion derived from the unmodified cysteine switch decreased as we exposed pro-MMP-7 to increasing mole ratios of HOCl (Fig. 10) . In contrast, the intensity of the ion derived from the oxygenated, cleaved cysteine switch increased. The optimal mole ratio of HOCl to pro-MMP-7 for oxygenation of the cysteine switch domain was similar to that observed for maximal activation of pro-MMP-7 (compare Figs. 7 and 10 ). This strongly suggests that oxygenation of the thiol residue converts the pro-enzyme to a proteolytically active form (Fig. 11) . DISCUSSION We demonstrated that HOCl oxygenates the thiol residue of the cysteine switch domain and that this event converts the latent form of MMP-7 to an active form (Fig. 11) . Our observations suggest that HOCl provides a pericellular mechanism for activation of latent MMPs. This mechanism also might apply to other oxidants, electrophiles, and reactive nitrogen species, which react readily with thiol residues. MMP activation might result from disruption of a bond between the enzyme's thiol residue and its catalytic zinc atom. Alternatively, oxygenation of the thiol might disrupt the pro-peptide's native conformation, allowing autolytic cleavage and access to the enzyme's active site. Dysregulation of proteolytic activity has been implicated in many pathological disorders, including arthritis, emphysema, and metastatic cancer. Proteolytic cleavage of MMPs is widely believed to be one important mechanism of zymogen activation, but our results suggest that generation of reactive species by phagocytes could play a role in regulating MMP activity during inflammation.
Lipid-laden macrophages of human atherosclerotic tissue express several MMPs, including MMP-1, -3, -7, -8, and -9 (6 -9). Collectively, these enzymes can degrade essentially all the major structural proteins in extracellular matrix, including native and fragmented collagens, elastin, basement membrane components, and the protein core of proteoglycans, as well as several non-matrix proteins. Studies by Weiss and colleagues (20, 21) demonstrated that HOCl markedly enhances the proteolytic activity of MMP-8 and MMP-9, two MMPs present in atherosclerotic tissue. Here, we demonstrate that HOCl also activates pro-MMP-7, which colocalizes with lipid-laden macrophages in vascular lesions (9) . Moreover, atherosclerotic lesions contain enzymatically active myeloperoxidase (31), the only known human source of HOCl at plasma concentrations of halide (32, 33, 52) , and data we present demonstrate that this enzyme colocalizes to the macrophages expressing MMP-7 (Fig. 6) .
Myeloperoxidase forms characteristic abnormal amino acids when it oxidizes proteins (27) . Previous studies indicate that greatly elevated levels of these markers occur in lipoproteins and proteins isolated from human atherosclerotic tissue (34 - 38). Moreover, myeloperoxidase is highly expressed in ruptured or eroded sites of human coronary atheroma, and proteins modified by HOCl are present at high concentrations in these regions of the artery wall (39) . These observations indicate that HOCl production by myeloperoxidase might represent a physiological mechanism for activating several MMPs, which, in turn, may trigger plaque rupture in the human artery wall. In our studies, when a synthetic peptide PRCGVPDVA, which mimics the cysteine switch domain of pro-MMP-7, was oxidized with HOCl, the peptide's thiol residue was converted to sulfinic acid, sulfonic acid, and a disulfide cross-linked dimer. In contrast, H 2 O 2 (the oxidizing substrate used by myeloperoxidase to produce HOCl) generated only the dimer. Moreover, exposing the peptide to HOCl or H 2 O 2 alone resulted in dramatically different progress curves and product yields. HOCl, but not H 2 O 2 , rapidly converted the peptide into oxidation products, with near-quantitative yield. These results indicate that the cysteine switch peptide reacts much more rapidly with HOCl than with H 2 O 2 and that only HOCl can oxidize the switch's thiol residue to sulfinic acid.
After we exposed pro-MMP-7 to concentrations of HOCl that activate it in vitro, tandem MS analysis identified the sulfinic acid derivative in its oxidized pro-domain. In contrast, this derivative was undetectable in MMP-7 exposed to H 2 O 2 . When pro-MMP-7 is converted to its active form in vitro, its prodomain is cleaved at Glu 77 -Tyr 78 (53) . If HOCl oxygenates the thiol residue of the pro-domain of pro-MMP-7 without activating the enzyme, the peptide C(SO 2 (52). Under acidic conditions and at plasma concentrations of halide, myeloperoxidase will use H 2 O 2 to quantitatively convert bromide to a brominating species that resembles hypobromous acid (50) . Human peroxidases also oxidize thiocyanate, a pseudohalide (54, 55). The major product of eosinophil peroxidase is hypothiocyanate and cyanate (54) at plasma concentrations of thiocyanate (20 -120 M), chloride, and bromide. Because intermediates produced in these reactions rapidly oxidize thiol residues, they also might regulate the activity of MMPs.
Of potential significance, MMP-7 lost activity when exposed to high molar ratios of HOCl, similar to that reported for pro-MMP-8 and pro-MMP-9 (20, 21) . These findings suggest that HOCl generation by phagocytes in vivo contributes to both the activation and inactivation of MMPs. Phagocytes store MMPs and myeloperoxidase in responsive secretory compartments; thus, degranulation of these cells could create high focal concentrations of both enzymes (28 -30) . Because the phagocyte NADPH oxidase is associated with the plasma membrane, production of H 2 O 2 , the oxidizing substrate for myeloperoxidase, is also localized to the cell surface. Moreover, because both MMP-7 and MMP-9 are activated by low concentrations of HOCl but disabled by higher concentrations of oxidant traditional enzyme kinetics cannot fully explain the regulation of MMP activity by reactive oxygen species in tissue or extracellular fluids. Instead, regulation is likely to be highly localized in both space and time by rapid local changes in the concentrations of proteinase and oxidants. Analogously, it is noteworthy that neutrophils produce evanescent "quantum bursts" of pericellular proteolytic activity when activated in vitro (56) . These highly compartmentalized bursts of proteolytic destruction result from localized discharge of azurophilic granules that contain human leukocyte elastase. In fact, quantum proteolysis by human leukocyte elastase has been proposed to promote the lung injury and emphysema seen in patients deficient in ␣ 1 -antitrypsin (56) . Therefore, regulation of proteolytic activity might depend critically on the local concentrations of oxidants and MMPs that exist near the phagocyte surface.
Our demonstration that HOCl activates pro-MMP-7 by oxygenating the thiol residue of the cysteine switch peptide provides an alternative, physiological pathway to the proteolytic cleavage mechanism traditionally associated with MMP activation (Fig. 11) . This mechanism also links degradation of matrix proteins by MMPs to activated phagocytes, the cellular hallmark of acute and chronic inflammation. In addition, our findings demonstrate that MMP-7 activity died with increased exposure to HOCl suggesting that post-translational oxidative modifications control both the activation and deactivation of enzyme activity. Furthermore, generation of oxidants by myeloperoxidase in vivo could confine MMP activation to highly regulated temporal bursts of pericellular proteolysis. Because matrix degradation has been implicated in a variety of diseases, these findings could have broad implications for understanding the control of tissue remodeling during inflammation.
